Sciences announced data from a two-and-a-half-year interim analysis from the ongoing Phase 3 ASSURE study, which showed that 81%, ...

Sciences presented the first in-depth look at full results from its pivotal Phase 3 PURPOSE 2 trial, which is studying ...

Gilead Sciences, Inc. (Nasdaq: GILD) today presented the first in-depth look at full results from its pivotal Phase 3 PURPOSE 2 trial (NCT04925752), which is studying twice-yearly lenacapavir, the ...

Night - Partly cloudy with a 56% chance of precipitation. Winds variable at 7 to 15 mph (11.3 to 24.1 kph). The overnight low will be 45 °F (7.2 °C). Partly cloudy with a high of 58 °F (14.4 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Gilead Sciences has taken a major step towards increasing global access to HIV prevention with the signing of royalty-free voluntary licensing agreements with six generic manufacturers, paving the ...

Gilead Sciences’ already dominant position in HIV pre-exposure prophylaxis (PrEP) has been consolidated by a new study showing that its twice-yearly injectable drug was 100% effective in ...

On Monday, posters featuring a map of "Greater Serbia," which includes the Republic of North Macedonia, were put up in central Belgrade.The posters showed the faces of US President-elect Donald ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

By Emily LaBarge The sprawling PST festival of more than 70 exhibitions doesn’t quite live up to its theme of art and science colliding. But there is a handful of impressive entries.